WallStreetZenWallStreetZen

NASDAQ: RLMD
Relmada Therapeutics Inc Stock Ownership - Who owns Relmada Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Relmada Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Sergio TraversaChief Executive Officer2024-01-3127,460$4.00
$109.76kBuy
Maged ShenoudaChief Financial Officer2024-01-316,875$4.06
$27.94kBuy
Chuck EnceCA and CO2024-01-3113,670$4.06
$55.43kBuy
Maged ShenoudaChief Financial Officer2024-01-3015,000$3.89
$58.32kBuy
Chuck EnceCA and CO2024-01-3014,500$3.87
$56.06kBuy
Sergio TraversaChief Executive Officer2024-01-3040,999$3.90
$159.94kBuy
Maged ShenoudaChief Financial Officer2024-01-2910,800$3.65
$39.45kBuy
Sergio TraversaChief Executive Officer2024-01-2931,541$3.71
$117.05kBuy
Chuck EnceCA and CO2024-01-2910,800$3.65
$39.44kBuy
Cedric OgormanChief Medical Officer2023-05-2310,000$3.18
$31.80kBuy

1 of 1

RLMD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RLMD insiders and whales buy or sell their stock.

RLMD Shareholders

What type of owners hold Relmada Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Deep Track Capital LP6.78%2,044,507$7.99MInstitution
Vanguard Group Inc4.34%1,310,805$5.13MInstitution
Acadian Asset Management LLC3.92%1,182,825$4.62MInstitution
Parsons Capital Management Inc3.15%949,841$3.71MInstitution
Opaleye Management Inc2.91%877,000$3.43MInstitution
Palo Alto Investors LP2.43%732,400$2.86MInstitution
Blackrock Inc1.90%572,743$2.24MInstitution
Citadel Advisors LLC1.24%375,658$1.47MInstitution
Two Sigma Advisers LP1.09%328,300$1.28MInstitution
Two Sigma Investments LP1.00%302,744$1.18MInstitution

1 of 3

RLMD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RLMD45.13%3.43%Net BuyingNet Buying
SEER54.70%45.30%Net BuyingNet Selling
RZLT21.83%78.17%Net BuyingNet Buying
VOR87.43%10.18%Net SellingNet Selling
CTXR16.86%7.74%
View Top Biotech Stocks

Relmada Therapeutics Stock Ownership FAQ

Who owns Relmada Therapeutics?

Relmada Therapeutics (NASDAQ: RLMD) is owned by 45.13% institutional shareholders, 3.43% Relmada Therapeutics insiders, and 51.43% retail investors. Sergio Traversa is the largest individual Relmada Therapeutics shareholder, owning 244,024.00 shares representing 0.81% of the company. Sergio Traversa's Relmada Therapeutics shares are currently valued at $941.93k.

If you're new to stock investing, here's how to buy Relmada Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.